Do you have any questions?
Don't hesitate to contact us. We are happy to answer your questions.
Events
Explore our upcoming congresses and events to find out when we are in a city or area near you. Or check out our archived posters and presentation abstracts below.
Next event to meet us: European Society for Blood and Marrow Transplantation (EBMT) 51st Annual Meeting
We look forward to seeing you at #EBMT25 from March 30 to April 2 in Florence, Italy to discuss the latest CAR-T therapy data and research.
Find out moreNext event to meet us: European Society for Blood and Marrow Transplantation (EBMT) 51st Annual Meeting
We look forward to seeing you at #EBMT25 from March 30 to April 2 in Florence, Italy to discuss the latest CAR-T therapy data and research.
Conferences and events calendar
Upcoming events
EBMT 51st Annual Meeting
March 30th - April 2nd 2025 | Florence, Italy
30th EHA Congress
June 12th - 15th 2025 | Milan, Italy
18th ICML (international conference on malignant lymphoma)
June 17th - 21th 2025 | Lugano, Switzerland
DGHO (Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 2025)
October 24th - 27th 2025 | Cologne, Germany
Past events
Tandem Meetings-Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
February 12th - 16th 2025 | Honolulu, USA
EHA-EBMT 7th European CAR T-cell Meeting
February 6th - 8th 2025 | Strasbourg, France
ASH – 66th American Society of Hematology Annual Meeting and Exposition 2024
December 7th - 10th 2024 | San Diego, USA
EHA - European Hematology Association Hybrid Congress
June 13th - 16th 2024 | Madrid, Spain
50th Annual Meeting of the EBMT
April 14th - 17th 2024 | Glasgow, Scotland
2024 Tandem Meetings of ASTCT™ and CIBMTR®
February 21th - 25th 2023 | San Antonio, Texas, USA
ASH – 65th American Society of Hematology Annual Meeting and Exposition 2023
December 9th-12th 2023 | San Diego, USA
DGHO 2023 – Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
October 13th - 16th 2023 | Hamburg, Germany
ESCHART 2023 – 2nd How I Manage CAR-T Therapies and Bispecific Antibodies for my patients
September 29th - October 1st 2023 | Berlin, Germany
17thICML – International Conference on Malignant Lymphoma
June 13rd - 17th 2023 | Lugano, Switzerland | hybrid event
EHA 2023 – European Hematology Association
June 8th - 11th 2023 | Frankfurt, Germany
EBMT – European Society for Blood and Marrow Transplantation 49th Annual Meeting 2023
April 23rd - 26th 2023 | Paris, France
2023 Tandem Meetings I Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
February 15th - 19th 2023 | Orlando, USA
EBMT – EHA 5th European CAR T-cell Meeting
February 9th - 11th 2023 | Rotterdam, Netherlands
CTI – Cell Therapy Innovation 360
January 25th - 26th 2023 | Lyon, France
ASH – 64th American Society of Hematology Annual Meeting and Exposition 2022
December 10th - 13th 2022 | New Orleans, USA
Latest resources from Miltenyi Biomedicine
View recent posters, presentations and press releases
Tandem CD20-CD19-Directed Non-Cryopreserved CAR T Cells - Zamtocabtagene Autoleucel (Zamto-Cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Interim Results from a Phase 2 Pivotal Study (DALY II USA)
Tandem Meetings – Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR | presentation slides
Interim Results from a Phase 2 Pivotal Study (DALY II USA) of Tandem CD20-CD19-Directed Non-Cryopreserved CAR-T Cells - Zamtocabtagene Autoleucel (zamto-cel) in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
ASH24 | presentation slides
Miltenyi Biomedicine will share positive interim results from DALY II USA at the American Society of Hematology (ASH) Annual Meeting
ASH 2024 | press release
Bispecific anti-CD20/19 CAR-T – zamtocabtagene autoleucel for relapsed/refractory DLCBL – interim analysis results of DALY-II-USA study
EHA2023 Hybrid Congress | poster information
Interim analysis of a Phase II study of administered fresh bispecific anti-CD20/anti-CD19 CAR T cell therapy zamtocabtagene autoleucel (zamto-cel) for relapsed/refractory (R/R) DLBCL (DALY II USA, NCT04792489)
Tandem Meetings of ASTCT and CIBMTR 2023 I presentation slides
PHASE I TRIAL OF MB-CART2019.1 IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON-HODGKIN LYMPHOMA
EHA 2022 | poster download
Characterization and T-Cell Repertoire of MB-CART2019.1 (Zamtocabtagene autoleucel) - Data from the Phase I Trial
ASH 2022 | presentation abstract
Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
ASH 2022 | presentation abstract
Survival Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL) - Real World Evidence from Germany
ASH 2022 | presentation abstract